sri ramya - Independent Researcher (original) (raw)

sri ramya

rodo pfister related author profile picture

Giulia Sissa related author profile picture

Isad Saric related author profile picture

Ela Akgün Özbek related author profile picture

Enock Mararo related author profile picture

Nghia Pham related author profile picture

Claudio Tennie related author profile picture

Will Beischel related author profile picture

Nicola De Pisapia related author profile picture

Jodie Cochrane Wilkie related author profile picture

Uploads

Papers by sri ramya

Research paper thumbnail of Metabolic Syndrome in Patients with Psychosis Using Second-Generation Antipsychotics

PARIPEX INDIAN JOURNAL OF RESEARCH

Background: Persons with Schizophrenia are more likely to die from cardiovascular illness and are... more Background: Persons with Schizophrenia are more likely to die from cardiovascular illness and are at a greater risk of developing obesity, diabetes mellitus (DM), hypertension (HTN), and dyslipidemias. Though the SGA were quite effective, their safety advantages have been questioned because of their propensity to induce weight gain and alter glucose,lipid metabolism. Objectives: 1.To study the incidence of metabolic syndrome (MS) due to selected SGA 2.To compare any differences in the metabolic profile of patients on various antipsychotics. Methodology: A Study was done for about a year among 120 Drug Naive patients with the diagnosis of schizophrenia or acute psychosis as per ICD 10 criteria,attending psychiatry OPD and were selected by systematic sampling method into four groups.With the Group (A) receiving Olanzapine, group (B) Risperidone, group (C) Quetiapine, group (D) Aripiprazole.Each group consisting of 30 patients.After 12 weeks of medication,Patients were screened for the...

Research paper thumbnail of Metabolic Syndrome in Patients with Psychosis Using Second-Generation Antipsychotics

PARIPEX INDIAN JOURNAL OF RESEARCH

Background: Persons with Schizophrenia are more likely to die from cardiovascular illness and are... more Background: Persons with Schizophrenia are more likely to die from cardiovascular illness and are at a greater risk of developing obesity, diabetes mellitus (DM), hypertension (HTN), and dyslipidemias. Though the SGA were quite effective, their safety advantages have been questioned because of their propensity to induce weight gain and alter glucose,lipid metabolism. Objectives: 1.To study the incidence of metabolic syndrome (MS) due to selected SGA 2.To compare any differences in the metabolic profile of patients on various antipsychotics. Methodology: A Study was done for about a year among 120 Drug Naive patients with the diagnosis of schizophrenia or acute psychosis as per ICD 10 criteria,attending psychiatry OPD and were selected by systematic sampling method into four groups.With the Group (A) receiving Olanzapine, group (B) Risperidone, group (C) Quetiapine, group (D) Aripiprazole.Each group consisting of 30 patients.After 12 weeks of medication,Patients were screened for the...

Log In